Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
This study has been completed.
Study NCT00004381   Information provided by Office of Rare Diseases (ORD)
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperbilirubinemia
Hemolytic Disease of Newborn
Additional conditions recognized in this trial
Erythroblastosis, Fetal
Glucosephosphate Dehydrogenase Deficiency
Hyperbilirubinemia, Neonatal
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Blood Group Incompatibility
Carbohydrate Metabolism, Inborn Errors
Fetal Diseases
Genetic Diseases, Inborn
Hematologic Diseases
Immune System Diseases
Infant, Newborn, Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Pathologic Processes
Pregnancy Complications
Interventions listed in this trial
tin mesoporphyrin
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Rockefeller University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services